ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Robotic Engineer at Multiply Labs - ApplyBlast

Robotic Engineer

Multiply Labs

3 months ago

Turin, Italy

Onsite

Full Time

Medior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Multiply Labs is seeking a hands‑on Robotic Engineer to join its integration and testing team, working on robotic cells that automate cell therapy manufacturing in a GMP environment. The role involves configuring and testing electromechanical devices, supporting software integration, and managing the full qualification cycle of robotic cells.

Responsibilities

Configure and test electromechanical devices for robotic cell qualification
Collaborate with electricians and assembly teams to diagnose issues
Execute test protocols using internal software ensuring traceability
Manage organization and documentation of tested devices and materials
Support software integration of new devices and peripherals

Skills

Qualifications

MSc in Mechanical Engineering, Mechatronics, Robotics, or related fieldPhD in Robotics or Autonomous SystemsValid driver's license (A/B)

About Multiply Labs

multiplylabs.com

Headquarters

San Francisco, California, United States

Company Size

11-50 employees

Founded

2016

View Profile

Multiply Labs builds robotic biomanufacturing infrastructure powered by Physical AI to automate the production of advanced biological therapies, including cell therapies, gene therapies, antibodies, and RNA therapies. Their platform — comprising autonomous robotic clusters, fully automated unit operations, and integrated GMP-compliant software — enables biopharma partners to scale throughput, reduce costs, and eliminate contamination risks associated with manual processes. The company serves life-science organizations seeking to modernize their manufacturing stack for the next generation of complex biological drugs.